Immunohistochemical analysis reveals a tumour suppressor-like role for the transcription factor AP-2 in invasive breast cancer
- 1 December 1999
- journal article
- research article
- Published by Wiley in The Journal of Pathology
- Vol. 189 (4), 514-520
- https://doi.org/10.1002/(sici)1096-9896(199912)189:4<514::aid-path463>3.0.co;2-9
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Enhanced apoptotic cell death of renal epithelial cells in mice lacking transcription factor AP-2βGenes & Development, 1997
- Identification of ERF-1 as a member of the AP2 transcription factor familyProceedings of the National Academy of Sciences, 1997
- Comparative analysis of AP-2α and AP-2β gene expression during murine embryogenesisDevelopmental Dynamics, 1997
- AP2 inhibits cancer cell growth and activates p21WAF1/CIP1 expressionNature Genetics, 1997
- Neural tube, skeletal and body wall defects in mice lacking transcription factor AP-2Nature, 1996
- Transcription factor AP-2 essential for cranial closure and craniofacial developmentNature, 1996
- AP-2.2, a novel gene related to AP-2, is expressed in the forebrain, limbs and face during mouse embryogenesisMechanisms of Development, 1996
- The developmentally regulated transcription factor AP-2 is involved in c-erbB-2 overexpression in human mammary carcinoma.Proceedings of the National Academy of Sciences, 1995
- The biology of erbB-2/nue/HER-2 and its role in cancerBiochimica et Biophysica Acta (BBA) - Reviews on Cancer, 1994
- Relationship between EGF-R, c-erbB-2 protein expression and Ki67 immunostaining in breast cancer and hormone sensitivityEuropean Journal Of Cancer, 1993